Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	alpha-amylase activity	AMY1A AMY1B AMY1C	2.10e-06	5	120	3	GO:0004556
GeneOntologyMolecularFunction	amylase activity	AMY1A AMY1B AMY1C	4.18e-06	6	120	3	GO:0016160
GeneOntologyMolecularFunction	cell adhesion molecule binding	ADAM15 ADAM9 PKP4 LARP1 ADAMTS13 ADAMTS8 EMILIN1 CNTN6 IQGAP1 PTPRD PTPRF PI4KA VCL	6.50e-05	599	120	13	GO:0050839
GeneOntologyMolecularFunction	chloride ion binding	AMY1A AMY1B AMY1C	1.12e-04	16	120	3	GO:0031404
GeneOntologyMolecularFunction	hydrolase activity, hydrolyzing O-glycosyl compounds	AMY1A AMY1B AMY1C GLA FUCA2	3.95e-04	103	120	5	GO:0004553
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNAH10 CCDC88B DNAH8	6.21e-04	28	120	3	GO:0051959
GeneOntologyMolecularFunction	metalloendopeptidase activity	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	7.92e-04	120	120	5	GO:0004222
Domain	ADAM_Cys-rich	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	6.40e-07	27	117	5	IPR006586
Domain	ACR	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	6.40e-07	27	117	5	SM00608
Domain	Glyco_hydro_b	AMY1A AMY1C GLA FUCA2	1.89e-06	15	117	4	IPR013780
Domain	DISINTEGRIN_1	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	4.89e-06	40	117	5	PS00427
Domain	Reprolysin	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	4.89e-06	40	117	5	PF01421
Domain	ADAM_MEPRO	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	4.89e-06	40	117	5	PS50215
Domain	DISINTEGRIN_2	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	4.89e-06	40	117	5	PS50214
Domain	Peptidase_M12B	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	4.89e-06	40	117	5	IPR001590
Domain	Disintegrin_dom	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	5.54e-06	41	117	5	IPR001762
Domain	ZF_CCHC_FOG	ZFPM1 ZFPM2	3.89e-05	2	117	2	PS51810
Domain	Aquaporin_12	AQP12A AQP12B	3.89e-05	2	117	2	IPR023265
Domain	-	AMY1A GLA FUCA2	8.29e-05	14	117	3	2.60.40.1180
Domain	Pep_M12B_propep	ADAMTS1 ADAM15 ADAM9 ADAMTS8	1.02e-04	39	117	4	PF01562
Domain	Peptidase_M12B_N	ADAMTS1 ADAM15 ADAM9 ADAMTS8	1.02e-04	39	117	4	IPR002870
Domain	Aquaporin_11/12	AQP12A AQP12B	1.16e-04	3	117	2	IPR016697
Domain	-	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	1.55e-04	81	117	5	3.40.390.10
Domain	MetalloPept_cat_dom	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	1.55e-04	81	117	5	IPR024079
Domain	Alpha_amylase	AMY1A AMY1C	2.32e-04	4	117	2	IPR006046
Domain	Aamy_C	AMY1A AMY1C	2.32e-04	4	117	2	SM00632
Domain	Glycoside_hydrolase_SF	AMY1A AMY1C GLA FUCA2	3.38e-04	53	117	4	IPR017853
Domain	ZINC_FINGER_C2H2_2	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 FOXP4 RBSN ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	3.50e-04	775	117	14	PS50157
Domain	ZINC_FINGER_C2H2_1	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 FOXP4 RBSN ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	3.59e-04	777	117	14	PS00028
Domain	ZINC_PROTEASE	ADAMTS1 ADAM15 ADAM9 ADAMTS13 ADAMTS8	3.78e-04	98	117	5	PS00142
Domain	Alpha-amylase_C	AMY1A AMY1C	3.84e-04	5	117	2	PF02806
Domain	A-amylase/branching_C	AMY1A AMY1C	3.84e-04	5	117	2	IPR006048
Domain	Peptidase_M12B_ADAM-TS	ADAMTS1 ADAMTS13 ADAMTS8	4.41e-04	24	117	3	IPR013273
Domain	Znf_C2H2-like	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 FOXP4 RBSN ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	4.57e-04	796	117	14	IPR015880
Domain	Znf_C2H2	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 FOXP4 RBSN ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	5.11e-04	805	117	14	IPR007087
Domain	ZnF_C2H2	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 FOXP4 RBSN ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	5.30e-04	808	117	14	SM00355
Domain	fn3	CNTN6 FNDC1 PTPRD PTPRF PTPRS CNTN3	5.49e-04	162	117	6	PF00041
Domain	Glyco_hydro_13_cat_dom	AMY1A AMY1C	8.00e-04	7	117	2	IPR006047
Domain	Alpha-amylase	AMY1A AMY1C	8.00e-04	7	117	2	PF00128
Domain	Aamy	AMY1A AMY1C	8.00e-04	7	117	2	SM00642
Domain	Villin/Gelsolin	FLII SCIN	1.06e-03	8	117	2	IPR007122
Domain	DHC_N1	DNAH10 DNAH8	1.06e-03	8	117	2	PF08385
Domain	GEL	FLII SCIN	1.06e-03	8	117	2	SM00262
Domain	Dynein_heavy_dom-1	DNAH10 DNAH8	1.06e-03	8	117	2	IPR013594
Domain	FN3	CNTN6 FNDC1 PTPRD PTPRF PTPRS CNTN3	1.10e-03	185	117	6	SM00060
Domain	-	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	1.14e-03	679	117	12	3.30.160.60
Domain	zf-C2H2	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	1.35e-03	693	117	12	PF00096
Domain	Znf_C2H2/integrase_DNA-bd	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	1.37e-03	694	117	12	IPR013087
Domain	PTPc	PTPRD PTPRF PTPRS	1.47e-03	36	117	3	SM00194
Domain	FN3	CNTN6 FNDC1 PTPRD PTPRF PTPRS CNTN3	1.59e-03	199	117	6	PS50853
Domain	Glyco_hydro_catalytic_dom	AMY1A AMY1C FUCA2	1.72e-03	38	117	3	IPR013781
Domain	TYR_PHOSPHATASE_PTP	PTPRD PTPRF PTPRS	1.86e-03	39	117	3	PS50055
Domain	FN3_dom	CNTN6 FNDC1 PTPRD PTPRF PTPRS CNTN3	2.04e-03	209	117	6	IPR003961
Domain	PTPase_domain	PTPRD PTPRF PTPRS	2.15e-03	41	117	3	IPR000242
Domain	Y_phosphatase	PTPRD PTPRF PTPRS	2.15e-03	41	117	3	PF00102
Domain	Class_I_gatase-like	TCAF1 PFAS	2.46e-03	12	117	2	IPR029062
Domain	WW	MAGI3 IQGAP1 WWC2	3.18e-03	47	117	3	PF00397
Domain	Gelsolin	FLII SCIN	3.37e-03	14	117	2	PF00626
Domain	Dynein_heavy_chain_D4_dom	DNAH10 DNAH8	3.37e-03	14	117	2	IPR024317
Domain	Dynein_HC_stalk	DNAH10 DNAH8	3.37e-03	14	117	2	IPR024743
Domain	MIP	AQP12A AQP12B	3.37e-03	14	117	2	PF00230
Domain	Dynein_heavy_dom-2	DNAH10 DNAH8	3.37e-03	14	117	2	IPR013602
Domain	DHC_N2	DNAH10 DNAH8	3.37e-03	14	117	2	PF08393
Domain	Gelsolin-like_dom	FLII SCIN	3.37e-03	14	117	2	IPR007123
Domain	ATPase_dyneun-rel_AAA	DNAH10 DNAH8	3.37e-03	14	117	2	IPR011704
Domain	MIP	AQP12A AQP12B	3.37e-03	14	117	2	PS00221
Domain	MT	DNAH10 DNAH8	3.37e-03	14	117	2	PF12777
Domain	AAA_8	DNAH10 DNAH8	3.37e-03	14	117	2	PF12780
Domain	AAA_5	DNAH10 DNAH8	3.37e-03	14	117	2	PF07728
Domain	WW	MAGI3 IQGAP1 WWC2	3.38e-03	48	117	3	SM00456
Domain	DHC_fam	DNAH10 DNAH8	3.87e-03	15	117	2	IPR026983
Domain	-	AQP12A AQP12B	3.87e-03	15	117	2	1.20.1080.10
Domain	Dynein_heavy	DNAH10 DNAH8	3.87e-03	15	117	2	PF03028
Domain	Aquaporin-like	AQP12A AQP12B	3.87e-03	15	117	2	IPR023271
Domain	MIP	AQP12A AQP12B	3.87e-03	15	117	2	IPR000425
Domain	Dynein_heavy_dom	DNAH10 DNAH8	3.87e-03	15	117	2	IPR004273
Domain	WW_DOMAIN_1	MAGI3 IQGAP1 WWC2	4.01e-03	51	117	3	PS01159
Domain	WW_DOMAIN_2	MAGI3 IQGAP1 WWC2	4.01e-03	51	117	3	PS50020
Domain	WW_dom	MAGI3 IQGAP1 WWC2	4.24e-03	52	117	3	IPR001202
Domain	CUB	ADAMTS13 NRP2 MEGF8	4.47e-03	53	117	3	PS01180
Domain	CUB_dom	ADAMTS13 NRP2 MEGF8	5.48e-03	57	117	3	IPR000859
Domain	ADAM_CR	ADAM15 ADAM9	5.58e-03	18	117	2	PF08516
Domain	PTPc_motif	PTPRD PTPRF PTPRS	6.04e-03	59	117	3	SM00404
Domain	Tyr_Pase_cat	PTPRD PTPRF PTPRS	6.04e-03	59	117	3	IPR003595
Domain	VWC_out	KCP VWCE	6.21e-03	19	117	2	SM00215
Pathway	KEGG_MEDICUS_REFERENCE_GLYCOGEN_DEGRADATION_AMYLASE_	AMY1A AMY1B AMY1C	1.86e-05	9	87	3	M47622
Pathway	REACTOME_DIGESTION_OF_DIETARY_CARBOHYDRATE	AMY1A AMY1B AMY1C	3.61e-05	11	87	3	M1091
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PTPRD PTPRF PTPRS	2.40e-04	20	87	3	M27290
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	PTPRD PTPRF PTPRS	2.40e-04	20	87	3	MM15485
Pathway	REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES	PTPRD PTPRF PTPRS	2.40e-04	20	87	3	MM14991
Pathway	REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES	PTPRD PTPRF PTPRS	2.79e-04	21	87	3	M27736
Pathway	REACTOME_DIGESTION	AMY1A AMY1B AMY1C	3.68e-04	23	87	3	M27790
Pubmed	Proteomic and Biochemical Comparison of the Cellular Interaction Partners of Human VPS33A and VPS33B.	FLII HDAC5 RREB1 CABLES1 PIKFYVE RBSN CUEDC2 CEP131 DNMBP KIF1C	2.35e-08	251	123	10	29778605
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	FLII COPA LARP1 DIDO1 TACC2 CABLES1 IQGAP1 USP10 RBSN CEP131 RBM8A TRIM47 KIF1C	3.00e-08	503	123	13	16964243
Pubmed	AMY1 Gene Copy Number Correlates With Glucose Absorption and Visceral Fat Volume, but Not with Insulin Resistance.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	32697825
Pubmed	Evidence of duplication of the human salivary amylase gene.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	6176528
Pubmed	State and trait variance in salivary α-amylase: a behavioral genetic study.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	21827821
Pubmed	LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses.	PTPRD PTPRF PTPRS	4.32e-08	3	123	3	31985401
Pubmed	Trans-synaptic adhesions between netrin-G ligand-3 (NGL-3) and receptor tyrosine phosphatases LAR, protein-tyrosine phosphatase delta (PTPdelta), and PTPsigma via specific domains regulate excitatory synapse formation.	PTPRD PTPRF PTPRS	4.32e-08	3	123	3	20139422
Pubmed	Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR.	PTPRD PTPRF PTPRS	4.32e-08	3	123	3	33656439
Pubmed	Structure of human salivary alpha-amylase at 1.6 A resolution: implications for its role in the oral cavity.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	15299664
Pubmed	Salivary alpha-amylase and cortisol responsiveness following electrical stimulation stress in major depressive disorder patients.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	22063648
Pubmed	Salivary α-amylase copy number is not associated with weight trajectories and glycemic improvements following clinical weight loss: results from a 2-phase dietary intervention study.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	30982860
Pubmed	Developmental expression of the cell adhesion molecule-like protein tyrosine phosphatases LAR, RPTPdelta and RPTPsigma in the mouse.	PTPRD PTPRF PTPRS	4.32e-08	3	123	3	9784606
Pubmed	Probing the role of a mobile loop in substrate binding and enzyme activity of human salivary amylase.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	12527308
Pubmed	Salivary alpha amylase diurnal pattern and stress response are associated with body mass index in low-income preschool-aged children.	AMY1A AMY1B AMY1C	4.32e-08	3	123	3	25588701
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLII CTC1 BICRA PFAS ZFPM1 DLL1 SYNE4 CABLES1 PIKFYVE PTPRF MEGF8 PTPRS PI4KA NINL CEP131 SNX15 CHPF DNMBP	7.18e-08	1105	123	18	35748872
Pubmed	The LAR/PTP delta/PTP sigma subfamily of transmembrane protein-tyrosine-phosphatases: multiple human LAR, PTP delta, and PTP sigma isoforms are expressed in a tissue-specific manner and associate with the LAR-interacting protein LIP.1.	PTPRD PTPRF PTPRS	1.72e-07	4	123	3	8524829
Pubmed	Primary structure of human salivary alpha-amylase gene.	AMY1A AMY1B AMY1C	1.72e-07	4	123	3	2423416
Pubmed	Multiple interactions between receptor protein-tyrosine phosphatase (RPTP) alpha and membrane-distal protein-tyrosine phosphatase domains of various RPTPs.	PTPRD PTPRF PTPRS	4.29e-07	5	123	3	10777529
Pubmed	Interleukin-1 receptor accessory protein organizes neuronal synaptogenesis as a cell adhesion molecule.	PTPRD PTPRF PTPRS	4.29e-07	5	123	3	22357843
Pubmed	Maturation of ureter-bladder connection in mice is controlled by LAR family receptor protein tyrosine phosphatases.	PTPRD PTPRF PTPRS	8.57e-07	6	123	3	19273906
Pubmed	Concerted evolution of human amylase genes.	AMY1A AMY1B AMY1C	8.57e-07	6	123	3	2452973
Pubmed	The human alpha-amylase multigene family consists of haplotypes with variable numbers of genes.	AMY1A AMY1B AMY1C	8.57e-07	6	123	3	2788608
Pubmed	Detection of large-scale variation in the human genome.	AMY1A AMY1B AMY1C	8.57e-07	6	123	3	15286789
Pubmed	Regional assignment of human amylase (AMY) to p22----p21 of chromosome 1.	AMY1A AMY1B AMY1C	8.57e-07	6	123	3	6608795
Pubmed	Evolution of the human alpha-amylase multigene family through unequal, homologous, and inter- and intrachromosomal crossovers.	AMY1A AMY1B AMY1C	8.57e-07	6	123	3	2081604
Pubmed	Intra- and intermolecular interactions between intracellular domains of receptor protein-tyrosine phosphatases.	PTPRD PTPRF PTPRS	1.50e-06	7	123	3	12376545
Pubmed	Modulation of apoptotic response by LAR family phosphatases-cIAP1 signaling during urinary tract morphogenesis.	PTPRD PTPRF PTPRS	1.50e-06	7	123	3	29073098
Pubmed	Abundance of ADAM-8, -9, -10, -12, -15 and -17 and ADAMTS-1 in mouse uterus during the oestrous cycle.	ADAMTS1 ADAM15 ADAM9	1.50e-06	7	123	3	15907280
Pubmed	AMY-1 interacts with S-AKAP84 and AKAP95 in the cytoplasm and the nucleus, respectively, and inhibits cAMP-dependent protein kinase activity by preventing binding of its catalytic subunit to A-kinase-anchoring protein (AKAP) complex.	AMY1A AMY1B AMY1C	2.39e-06	8	123	3	12414807
Pubmed	Combinatorial expression of neurexins and LAR-type phosphotyrosine phosphatase receptors instructs assembly of a cerebellar circuit.	PTPRD PTPRF PTPRS	2.39e-06	8	123	3	37591863
Pubmed	Protein Tyrosine Phosphatase δ Mediates the Sema3A-Induced Cortical Basal Dendritic Arborization through the Activation of Fyn Tyrosine Kinase.	PTPRD PTPRF PTPRS	2.39e-06	8	123	3	28637841
Pubmed	HSF1 phosphorylation establishes an active chromatin state via the TRRAP-TIP60 complex and promotes tumorigenesis.	FOXM1 FLII COPA DIDO1 PFAS EMILIN1 CLIP3 PTPRF PI4KA NUP93 SEC63 TRIM47 MAP3K19	2.91e-06	754	123	13	35906200
Pubmed	Two-hybrid analysis of human salivary mucin MUC7 interactions.	AMY1A AMY1B AMY1C	3.57e-06	9	123	3	16203048
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	FOXM1 FLII COPA LARP1 DIDO1 ZFPM1 RREB1 IQGAP1 PASK USP10 WWC2 RBM8A DNMBP	3.86e-06	774	123	13	15302935
Pubmed	Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling.	NCR3LG1 NRP2 PTPRF PTPRS NUP93	4.13e-06	67	123	5	21875946
Pubmed	Protein interactome reveals converging molecular pathways among autism disorders.	MAGI3 TACC2 VWCE CCDC88B CD163 ZFPM2 CUEDC2 MEGF8 RALBP1 NINL KIF1C	5.19e-06	560	123	11	21653829
Pubmed	LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.	TCAF1 COPA ADAMTS1 ADAM15 ADAM9 TM9SF3 IQGAP1 GLA PTPRF PI4KA RAB3GAP2 NUP93 SEC63 CHPF	6.52e-06	942	123	14	31073040
Pubmed	PTPσ functions as a presynaptic receptor for the glypican-4/LRRTM4 complex and is essential for excitatory synaptic transmission.	PTPRD PTPRF PTPRS	6.98e-06	11	123	3	25624497
Pubmed	A novel receptor-type protein tyrosine phosphatase with a single catalytic domain is specifically expressed in mouse brain.	PTPRD PTPRF PTPRS	6.98e-06	11	123	3	7832766
Pubmed	Salivary protein profiles are linked to bitter taste acceptance in infants.	AMY1A AMY1B AMY1C	6.98e-06	11	123	3	24248522
Pubmed	Cell Surface Proteomic Map of HIV Infection Reveals Antagonism of Amino Acid Metabolism by Vpu and Nef.	SPN NCR3LG1 CABLES1 PTPRF PTPRS PRRT3	7.88e-06	132	123	6	26439863
Pubmed	Cooperative polarization of MCAM/CD146 and ERM family proteins in melanoma.	ADAM9 PKP4 CABLES1 IQGAP1 NRP2 PTPRF TIAM1 ARHGAP31 PTPRS	8.34e-06	377	123	9	38117590
Pubmed	Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-interacting proteins.	PTPRD PTPRF PTPRS	9.28e-06	12	123	3	9624153
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	TCAF1 KIAA0586 MAGI3 PFAS WDFY4 CRY2 PIKFYVE SCIN KIF1C CCSER1	1.08e-05	493	123	10	15368895
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	WDR33 ADAM15 LARP1 NHLRC2 RREB1 PIKFYVE CUEDC2 RAB3GAP2 CEP131 SEC63 ITPRIPL1 VCL	1.20e-05	733	123	12	34672954
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	LARP1 MAGI3 WWC2 RBSN TIAM1 MEGF8 PI4KA RAB3GAP2 CEP131 NUP93 DNMBP KIF1C CCSER1	1.20e-05	861	123	13	36931259
Pubmed	Copy number variation of human AMY1 is a minor contributor to variation in salivary amylase expression and activity.	AMY1A AMY1B	1.24e-05	2	123	2	28219410
Pubmed	Transcriptional cofactors of the FOG family interact with GATA proteins by means of multiple zinc fingers.	ZFPM1 ZFPM2	1.24e-05	2	123	2	10329627
Pubmed	The mouse gene Ptprf encoding the leukocyte common antigen-related molecule LAR: cloning, characterization, and chromosomal localization.	PTPRD PTPRF	1.24e-05	2	123	2	7665159
Pubmed	METH-1, a human ortholog of ADAMTS-1, and METH-2 are members of a new family of proteins with angio-inhibitory activity.	ADAMTS1 ADAMTS8	1.24e-05	2	123	2	10438512
Pubmed	Genetic analysis of the aquaporin water channels AQP12A and AQP12B in patients with chronic pancreatitis.	AQP12A AQP12B	1.24e-05	2	123	2	36167651
Pubmed	The role of ADAMTS genes in the end stage of hip osteoarthritis.	ADAMTS1 ADAMTS8	1.24e-05	2	123	2	30655094
Pubmed	PI4KA and PIKfyve: Essential phosphoinositide signaling enzymes involved in myriad human diseases.	PIKFYVE PI4KA	1.24e-05	2	123	2	37453227
Pubmed	CRY2 is suppressed by FOXM1 mediated promoter hypermethylation in breast cancer.	FOXM1 CRY2	1.24e-05	2	123	2	28579430
Pubmed	Identification of a novel aquaporin, AQP12, expressed in pancreatic acinar cells.	AQP12A AQP12B	1.24e-05	2	123	2	15809071
Pubmed	Genome-wide identification and spatiotemporal expression profiling of zinc finger SWIM domain-containing protein family genes.	ZSWIM3 ZSWIM9	1.24e-05	2	123	2	37161653
Pubmed	Pancreas-specific aquaporin 12 null mice showed increased susceptibility to caerulein-induced acute pancreatitis.	AQP12A AQP12B	1.24e-05	2	123	2	19726746
Pubmed	The second catalytic domain of protein tyrosine phosphatase delta (PTP delta) binds to and inhibits the first catalytic domain of PTP sigma.	PTPRD PTPRS	1.24e-05	2	123	2	9566880
Pubmed	Appetite-regulating hormones from the upper gut: disrupted control of xenin and ghrelin in night workers.	GHRL COPA	1.24e-05	2	123	2	23199168
Pubmed	A scan of chromosome 10 identifies a novel locus showing strong association with late-onset Alzheimer disease.	SFTPD TM9SF3 PKD2L1 TACC2 NHLRC2 WDFY4 CUEDC2 DNMBP VCL	1.79e-05	415	123	9	16385451
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	HAUS5 LARP1 DIDO1 IQGAP1 PASK USP10 ARHGAP31 NINL NUP93 DNMBP	1.97e-05	529	123	10	14621295
Pubmed	Notch gene expression during pancreatic organogenesis.	AMY1B AMY1C DLL1	2.34e-05	16	123	3	10842072
Pubmed	Signal sequence and keyword trap in silico for selection of full-length human cDNAs encoding secretion or membrane proteins from oligo-capped cDNA libraries.	ADAM15 TM9SF3 WFDC1 EMILIN1 DRAXIN RBM8A FUCA2 SEC63 SCIN	2.36e-05	430	123	9	16303743
Pubmed	Protein tyrosine phosphatases expression during development of mouse superior colliculus.	PTPRD PTPRF PTPRS	2.83e-05	17	123	3	19727691
Pubmed	Expression of members of a novel membrane linked metalloproteinase family (ADAM) in human articular chondrocytes.	ADAM15 ADAM9	3.71e-05	3	123	2	9016778
Pubmed	Flightless anchors IQGAP1 and R-ras to mediate cell extension formation and matrix remodeling.	FLII IQGAP1	3.71e-05	3	123	2	32432944
Pubmed	Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42-Tuba pathway.	DDR1 DNMBP	3.71e-05	3	123	2	25422375
Pubmed	CircPI4KA Overexpression Enhances Carcinogenesis and Glycolysis Metabolism in Papillary Thyroid Carcinoma by Causing the miR-1287-5p-Mediated NRP2 Expression Elevation.	NRP2 PI4KA	3.71e-05	3	123	2	37813099
Pubmed	Role of the small GTPase activating protein IQGAP1 in collagen phagocytosis.	FLII IQGAP1	3.71e-05	3	123	2	32643295
Pubmed	ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.	ADAM15 ADAM9	3.71e-05	3	123	2	27554339
Pubmed	ADAM10, the rate-limiting protease of regulated intramembrane proteolysis of Notch and other proteins, is processed by ADAMS-9, ADAMS-15, and the gamma-secretase.	ADAM15 ADAM9	3.71e-05	3	123	2	19213735
Pubmed	Proteolytic processing of delta-like 1 by ADAM proteases.	ADAM9 DLL1	3.71e-05	3	123	2	17107962
Pubmed	Chondroitin Sulfate Proteoglycans Negatively Modulate Spinal Cord Neural Precursor Cells by Signaling Through LAR and RPTPσ and Modulation of the Rho/ROCK Pathway.	PTPRD PTPRF	3.71e-05	3	123	2	25703008
Pubmed	Structural basis for LAR-RPTP/Slitrk complex-mediated synaptic adhesion.	PTPRD PTPRS	3.71e-05	3	123	2	25394468
Pubmed	Differentially regulated ADAMTS1, 8, and 18 in gastric adenocarcinoma.	ADAMTS1 ADAMTS8	3.71e-05	3	123	2	28814085
Pubmed	ADAM-9, ADAM-15, and ADAM-17 are upregulated in macrophages in advanced human atherosclerotic plaques in aorta and carotid and femoral arteries--Tampere vascular study.	ADAM15 ADAM9	3.71e-05	3	123	2	19253070
Pubmed	A genome-wide screen to identify transcription factors expressed in pelvic Ganglia of the lower urinary tract.	FOXM1 DIDO1 TACC2 PIKFYVE FOXP4 RBSN ZNF358 ZNF746 ZFHX2 TBXT TRIM47	4.57e-05	709	123	11	22988430
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	FOXM1 HDAC5 WDR33 PFAS TACC2 PIKFYVE PI4KA CEP131 DNMBP SCIN	4.80e-05	588	123	10	38580884
Pubmed	Large-scale mapping of human protein-protein interactions by mass spectrometry.	AMY1A AMY1B AMY1C WDR33 LARP1 PFAS DOK2 IQGAP1 PASK TIAM1 PTPRS RAB3GAP2 NUP93 SEC63 BRF2	5.00e-05	1284	123	15	17353931
Pubmed	Genome-wide association for abdominal subcutaneous and visceral adipose reveals a novel locus for visceral fat in women.	DNAH10 WFDC1 RREB1 CNTN6 CRY2 TBXT	6.70e-05	193	123	6	22589738
Pubmed	Low Copy Number of the AMY1 Locus Is Associated with Early-Onset Female Obesity in Finland.	AMY1B AMY1C	7.41e-05	4	123	2	26132294
Pubmed	Characterization of the amino termini of mouse salivary and pancreatic amylases.	AMY1B AMY1C	7.41e-05	4	123	2	6165618
Pubmed	Multiple polyadenylation sites in a mouse alpha-amylase gene.	AMY1B AMY1C	7.41e-05	4	123	2	6166922
Pubmed	Structural forms of the human amylase locus and their relationships to SNPs, haplotypes and obesity.	AMY1B AMY1C	7.41e-05	4	123	2	26098870
Pubmed	Friend of GATA and GATA-6 modulate the transcriptional up-regulation of hepcidin in hepatocytes during inflammation.	ZFPM1 ZFPM2	7.41e-05	4	123	2	24179092
Pubmed	Dynamic changes in the expression of protein tyrosine phosphatases during preimplantation mouse development: semi-quantification by real-time PCR.	PTPRF PTPRS	7.41e-05	4	123	2	14967925
Pubmed	Electrophoretic variation of alpha-amylase in two inbred strains of Mus musculus.	AMY1B AMY1C	7.41e-05	4	123	2	4745489
Pubmed	Genetic variation in mouse salivary amylase rate of synthesis.	AMY1B AMY1C	7.41e-05	4	123	2	94264
Pubmed	Histone lysine methyltransferase Wolf-Hirschhorn syndrome candidate 1 is involved in human carcinogenesis through regulation of the Wnt pathway.	IQGAP1 TIAM1	7.41e-05	4	123	2	22028615
Pubmed	The two promoters of the mouse alpha-amylase gene Amy-1a are differentially activated during parotid gland differentiation.	AMY1B AMY1C	7.41e-05	4	123	2	3872721
Pubmed	A salivary amylase transgene is efficiently expressed in liver but not in parotid gland of transgenic mice.	AMY1B AMY1C	7.41e-05	4	123	2	2476716
Pubmed	Protein Tyrosine Phosphatase PTPRS Is an Inhibitory Receptor on Human and Murine Plasmacytoid Dendritic Cells.	PTPRF PTPRS	7.41e-05	4	123	2	26231120
Pubmed	A single mouse alpha-amylase gene specifies two different tissue-specific mRNAs.	AMY1B AMY1C	7.41e-05	4	123	2	6162570
Pubmed	Additional evidence for the close linkage of amy-1 and amy-2 in the mouse.	AMY1B AMY1C	7.41e-05	4	123	2	6163812
Pubmed	Members of the Amy-2 alpha-amylase gene family of mouse strain CE/J contain duplicated 5' termini.	AMY1B AMY1C	7.41e-05	4	123	2	2987507
Pubmed	Termination of transcription in the mouse alpha-amylase gene Amy-2a occurs at multiple sites downstream of the polyadenylation site.	AMY1B AMY1C	7.41e-05	4	123	2	6091898
Pubmed	The mouse alpha-amylase multigene family. Sequence organization of members expressed in the pancreas, salivary gland and liver.	AMY1B AMY1C	7.41e-05	4	123	2	6176715
Pubmed	Mouse liver and salivary gland alpha-amylase mRNAs differ only in 5' non-translated sequences.	AMY1B AMY1C	7.41e-05	4	123	2	6162108
Pubmed	On the genetic polymorphism of the serum alpha-amylase in the population of the south western Bulgaria (second communication).	AMY1A AMY1B	7.41e-05	4	123	2	16152770
Pubmed	ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia.	ADAMTS1 ADAMTS13	7.41e-05	4	123	2	29135310
Interaction	NPHP1 interactions	FLII COPA ADAM15 TM9SF3 IQGAP1 ZNF746 SEC63 DNMBP	1.18e-06	130	121	8	int:NPHP1
Interaction	DLL1 interactions	DDR1 MAGI3 DLL1 PTPRF PTPRS	3.08e-06	38	121	5	int:DLL1
Interaction	VPS33A interactions	FLII HDAC5 RREB1 CABLES1 PIKFYVE RBSN CUEDC2 CEP131 KIF1C	2.24e-05	253	121	9	int:VPS33A
Cytoband	3p26-p25	GHRL CNTN6	2.13e-05	3	123	2	3p26-p25
Cytoband	1p21	AMY1A AMY1B AMY1C	3.65e-05	24	123	3	1p21
Cytoband	19q13.12	HAUS5 SYNE4 CLIP3	9.78e-04	72	123	3	19q13.12
Cytoband	2q37.3	AQP12A AQP12B PASK	1.19e-03	77	123	3	2q37.3
Cytoband	Ensembl 112 genes in cytogenetic band chr10q24	TM9SF3 PKD2L1 CUEDC2 DNMBP	1.72e-03	189	123	4	chr10q24
Cytoband	Ensembl 112 genes in cytogenetic band chr1p21	AMY1A AMY1B AMY1C	3.04e-03	107	123	3	chr1p21
GeneFamily	ADAM metallopeptidases with thrombospondin type 1 motif	ADAMTS1 ADAMTS13 ADAMTS8	8.27e-05	19	82	3	50
GeneFamily	Fibronectin type III domain containing	CNTN6 FNDC1 PTPRD PTPRF PTPRS CNTN3	8.79e-05	160	82	6	555
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZNF133 ZKSCAN2 ZFPM1 RREB1 ZFPM2 ZNF71 ZBTB37 ZNF358 ZNF746 ZNF641 ZFHX2 ZNF84	9.08e-05	718	82	12	28
GeneFamily	Protein tyrosine phosphatases, receptor type	PTPRD PTPRF PTPRS	1.13e-04	21	82	3	813
GeneFamily	Gelsolin/villins	FLII SCIN	5.59e-04	8	82	2	950
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	CNTN6 PTPRD PTPRF PTPRS CNTN3	8.27e-04	161	82	5	593
GeneFamily	Aquaporins	AQP12A AQP12B	1.78e-03	14	82	2	305
GeneFamily	Zinc fingers C2HC-type\|PHD finger proteins\|Lysine acetyltransferases	ZFPM1 ZFPM2	2.34e-03	16	82	2	66
GeneFamily	Dyneins, axonemal	DNAH10 DNAH8	2.64e-03	17	82	2	536
GeneFamily	ADAM metallopeptidase domain containing\|CD molecules	ADAM15 ADAM9	6.63e-03	27	82	2	47
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic\|LPS_only / Treatment groups by lineage, cell group, cell type	TCAF1 ADAMTS1 PPP1R12B WFDC1 TACC2 ADAMTS13 ZFPM2 FNDC1 VCL	4.81e-09	200	123	9	02cae2c296a13ad4cbb53bca7a86d64629d67d66
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 CNTN3 VCL	8.81e-08	200	123	8	c596a53c0b63c9deaac7d99fcbdd94ecfa96b86c
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 NUP93 VCL	8.81e-08	200	123	8	8988f113708eef7d9d2a6a6c1bcfd7c8f9804d3e
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 NUP93 VCL	8.81e-08	200	123	8	dcdaec3ca3a3024dc1b8788c417003f84c2bffdc
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 CTC1 ADAMTS13 FNDC1 NUDT6 PTPRF CHPF	2.79e-07	157	123	7	f086753b51860e23f1275bd75e8802d2a7d7b70a
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-non-classical_monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN ZFPM1 HEXIM1 FOXP4 CD80 ZFHX2 SLC39A5	5.37e-07	173	123	7	c31076c725f4cd912c56903592a2d9356ae59f54
ToppCell	facs-Lung-Endomucin_-18m-Myeloid-Nonclassical_Monocyte\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPN ZFPM1 HEXIM1 FOXP4 CD80 ZFHX2 SLC39A5	5.37e-07	173	123	7	a4ed191cfdf6588b7f3672995bf0a4fe9e4b8df6
ToppCell	COVID-19-Epithelial_cells-AT1\|COVID-19 / group, cell type (main and fine annotations)	MAGI3 TACC2 CNTN6 WWC2 PTPRF TMC5 CCSER1	6.76e-07	179	123	7	a0b33bd69ffdfd5d38d80207fb40058a490aa19e
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 PPP1R12B WFDC1 EMILIN1 ZFPM2 FNDC1 CNTN3	8.43e-07	185	123	7	e64e8c98dd88d91f6501d3fb10b60fd2f3c90af3
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 PPP1R12B TACC2 ZFPM2 CLIP3 FNDC1 CNTN3	9.39e-07	188	123	7	293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PKP4 KCP MAGI3 TACC2 RALBP1 SCIN CCSER1	1.24e-06	196	123	7	c7136b1c83bcf907eec3b02b151fa061298b6672
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ADAMTS1 PPP1R12B WFDC1 TACC2 ADAMTS8 FNDC1 VCL	1.33e-06	198	123	7	2d0c14f8cabab99bc6d7c27685437c78841c7245
ToppCell	wk_15-18-Mesenchymal-Myofibro_&_SMC\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	ADAMTS1 PPP1R12B WFDC1 TACC2 ADAMTS8 FNDC1 VCL	1.33e-06	198	123	7	c9c96066c7fa897b583657f0b77ea093920ae9ba
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SFTPD MAGI3 TACC2 CNTN6 WWC2 PTPRF TMC5	1.37e-06	199	123	7	aca81a879ef9c196bd1885eff4c63ffe6c9682b7
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAM9 TM9SF3 TACC2 CNTN3 TMC5 SCIN CCSER1	1.42e-06	200	123	7	c450a15e21fa72d071ed6e3b9f22de557a0f3cea
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 VCL	1.42e-06	200	123	7	87827041663013f5e7273168dc8709d69840e7ce
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 VCL	1.42e-06	200	123	7	593bf6a7c557437db9a9249a5058a46014179ef6
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 VCL	1.42e-06	200	123	7	08bf8c00eee6468215edb3611296bfc8784c4d56
ToppCell	LPS_only-Mesenchymal_myocytic\|LPS_only / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 TACC2 ADAMTS8 FNDC1 VCL	1.42e-06	200	123	7	8bc9923f82bfb836e2f524204c92050edeae8ca5
ToppCell	Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GHRL DOK2 WDFY4 ARHGAP31 CD80 GIMAP6	3.15e-06	145	123	6	778655fffd73df101e656154a41b478a1b695116
ToppCell	Nasal_Brush-Epithelial-Basal_2\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	JPH4 ADAMTS1 ZFPM2 FNDC1 PTPRD MRGPRX3	9.57e-06	176	123	6	fc5787946f5a10056d326d070620575ae4081836
ToppCell	Nasal_Brush-Epithelial-Basal_2\|Epithelial / Tissue, Lineage and Cell class of Lung Cells from 10X	JPH4 ADAMTS1 ZFPM2 FNDC1 PTPRD MRGPRX3	9.57e-06	176	123	6	5daaba0853afe7d20d4635169ccd4f96e735b938
ToppCell	wk_08-11-Epithelial-Proximal_epithelial-Ciliated\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	AMY1A AMY1B DNAH10 TMC5 MAP3K19 LRRC74B	1.12e-05	181	123	6	8eed9d46d924b16f6dd1a025ff612244b02b4391
ToppCell	ASK454-Epithelial\|ASK454 / Donor, Lineage and Cell class of Lung cells from Dropseq	FOXM1 TACC2 ARMCX5 WWC2 PTPRF CD80	1.16e-05	182	123	6	ab15316cff989b61ff397a866d7ca8b49c13e981
ToppCell	COVID-19-lung-AT1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	MAGI3 TACC2 CNTN6 WWC2 PTPRF TMC5	1.19e-05	183	123	6	7b1a385ed54f93bfe85bf0c162e42d05d516b45c
ToppCell	COVID-19-lung-AT1\|lung / Disease (COVID-19 only), tissue and cell type	MAGI3 TACC2 CNTN6 WWC2 PTPRF TMC5	1.19e-05	183	123	6	942530449e9c6583705eeb8f6f12621daea57252
ToppCell	Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MAGI3 TACC2 CNTN6 WWC2 PTPRF TMC5	1.23e-05	184	123	6	29c95b814a0b1ad8734ed68b77df29c08594e5ec
ToppCell	Control-Epithelial-ATI\|World / Disease state, Lineage and Cell class	SFTPD MAGI3 TACC2 CNTN6 WWC2 PTPRF	1.27e-05	185	123	6	0563d5042bb96ecce8446fbf26d05ef7a45e23c5
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 PPP1R12B WFDC1 ZFPM2 CLIP3 FNDC1	1.31e-05	186	123	6	6add08d4ca019ff2864acdd5ec2c66a59a574591
ToppCell	LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SFTPD MAGI3 TACC2 CNTN6 FOXP4 PTPRF	1.31e-05	186	123	6	4e94158db52df41d71e67b02b9895a358eebee0f
ToppCell	LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	DDR1 SFTPD MAGI3 CNTN6 FOXP4 PTPRF	1.35e-05	187	123	6	58d48128547ee3513d0bf7f78e61b76b1c472ca9
ToppCell	COVID-19-Epithelial_cells\|COVID-19 / group, cell type (main and fine annotations)	SFTPD MAGI3 TACC2 PTPRF TMC5 CCSER1	1.39e-05	188	123	6	c9cdee6f8d42ee69f5fb335f25084603c511bd29
ToppCell	Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADAMTS1 WFDC1 TACC2 ADAMTS8 FNDC1 VCL	1.39e-05	188	123	6	4d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell	facs-GAT-Fat-3m\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	COPA ADAM15 TM9SF3 WFDC1 PTPRS VCL	1.48e-05	190	123	6	1d92be1b41cff59e834a9d28868f554bd1f3e471
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFDC1 CLIP3 FNDC1 PTPRF PTPRS CHPF	1.52e-05	191	123	6	9214655dca96d766737c9f30b624d7fe7050342e
ToppCell	LPS_only-Stromal_mesenchymal-Lung_smooth_muscle\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 PPP1R12B WFDC1 EMILIN1 ZFPM2 FNDC1	1.52e-05	191	123	6	08042952431ca1a6fd7dfc13f36eb28643979598
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 PPP1R12B KCP WFDC1 CLIP3 FNDC1	1.52e-05	191	123	6	7853ac7dff649150e6ff27cd4c8cf7c1fc034ed4
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ADAMTS1 PPP1R12B WFDC1 ZFPM2 CLIP3 FNDC1	1.57e-05	192	123	6	992d08092edbc68c47b945deb8708379738c239a
ToppCell	facs-Aorta-Heart-3m-Mesenchymal\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFDC1 CLIP3 FNDC1 PTPRF PTPRS CHPF	1.57e-05	192	123	6	0dc1f46e40346ed0b286e53b106a812441575100
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	KCP TACC2 PTPRF RALBP1 TMC5 CCSER1	1.66e-05	194	123	6	04bfc555743f7d8821439d05ae442d15e9886c59
ToppCell	wk_20-22-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	ADAMTS1 PPP1R12B WFDC1 TACC2 FNDC1 VCL	1.71e-05	195	123	6	4dba732c8d8ecf0ed9ece1814dc4060402199ed9
ToppCell	nucseq-Epithelial\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SFTPD MAGI3 TACC2 WWC2 PTPRF TMC5	1.71e-05	195	123	6	9406866f99555198a9be311fbd65751b70f35446
ToppCell	facs-Aorta-Heart-3m-Mesenchymal-fibroblast_of_cardiac_tissue\|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	WFDC1 CLIP3 FNDC1 PTPRF PTPRS CHPF	1.76e-05	196	123	6	2029f58ce6a7b8c35d3a7496c3341391990909ce
ToppCell	PBMC-Control-cDC_3\|Control / Compartment, Disease Groups and Clusters	COPA DIDO1 WDFY4 PI4KA VCL LRRC74B	1.76e-05	196	123	6	09d197b321ff9f13c0672ea059c850845b0dbbd5
ToppCell	LPS_anti-TNF-Epithelial_alveolar-AT_1-Differentiating_AT2\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SFTPD MAGI3 CNTN6 WWC2 FOXP4 PTPRF	1.81e-05	197	123	6	3d13a4f2e86422900ee2194e8a1fd1cf9750d5d3
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	FOXM1 AMY1B ZFHX2 CNTN3 MAP3K19 LRRC74B	1.81e-05	197	123	6	6e4a411ef823ce9e16f420e185e21fa19d13af34
ToppCell	distal-3-mesenchymal-Fibromyocyte\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	ADAMTS1 WFDC1 ADAMTS8 EMILIN1 FNDC1 CNTN3	1.87e-05	198	123	6	dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADAMTS1 PPP1R12B WFDC1 TACC2 ADAMTS8 FNDC1	1.87e-05	198	123	6	637f11e292b90d86cdc0d0d828eb26f38289c25b
ToppCell	Bronchial-10x5prime-Epithelial-Epi_alveolar-AT1\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	SFTPD MAGI3 CNTN6 WWC2 PTPRF TMC5	1.87e-05	198	123	6	54228dd9a50616d2022712d162a419ed0327cabd
ToppCell	moderate-Epithelial-Secretory\|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	DDR1 ADAM15 ADAM9 TM9SF3 MAGI3 VCL	1.87e-05	198	123	6	7d96d7105a849c7280ce87bd76ce130ac47384fd
ToppCell	cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ADAMTS1 PPP1R12B WFDC1 ADAMTS8 EMILIN1 FNDC1	1.87e-05	198	123	6	e9f434bfd072e590fe44d518057ee5aa653038f3
ToppCell	Parenchymal-10x3prime_v2-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	PPP1R12B NHLRC2 ADAMTS8 PTPRS ZNF84 KIF1C	1.87e-05	198	123	6	cc2b5b632e73e44bb60050f0db10d8f0dbb859fa
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	1ee4010d8557564e25e8ee00b914c2dfd9037838
ToppCell	BAL-Mild-Epithelial-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	1df69c0cb5f759f6a2152521842506a75bb95cae
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDR1 SFTPD MAGI3 TACC2 PTPRF TMC5	1.92e-05	199	123	6	b44d74895846e2ac144438b73e0ca91e3949c16c
ToppCell	wk_08-11-Mesenchymal-Myofibro_&_SMC-Early_airway_SMC_2\|wk_08-11 / Celltypes from embryonic and fetal-stage human lung	ADAMTS1 PPP1R12B WFDC1 TACC2 ADAMTS8 FNDC1	1.92e-05	199	123	6	a207b4891881149d4c50721310690fd794157723
ToppCell	Mild-Epithelial-Epithelial-\|Mild / Condition, Lineage, Cell class and cell subclass	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	81115bbd2c10bfdd38376d2075f03a59c31870d2
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 ZFPM2 FNDC1 VCL	1.92e-05	199	123	6	e9820d5fb4e8b46973c4c50ac5db8fb4a1bf603b
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Transitional_AT2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDR1 SFTPD MAGI3 TACC2 PTPRF TMC5	1.92e-05	199	123	6	4b374a5de82b4614d3d8a00202ea6cb8f1fd8104
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	74087b4b5e567310fc4ac58fb267ff651a180680
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	TCAF1 ADAMTS1 PPP1R12B WFDC1 ADAMTS13 ZFPM2	1.92e-05	199	123	6	38cfd367ee8c074c11ba54edeb7a001e375e2687
ToppCell	BAL-Mild-Epithelial\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	00b5ce099c50a5e1786ce2b3a06ee0931a8205a4
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Transitional_AT2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	DDR1 SFTPD MAGI3 TACC2 PTPRF TMC5	1.92e-05	199	123	6	9e8231c9007d8d963805a4c99e0905538ceb9b60
ToppCell	Mild-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	ec5fff80e2a8a94fbaf1fdcc6d45c8d7c6252e18
ToppCell	Mild-Epithelial-Epithelial\|Mild / Condition, Lineage, Cell class and cell subclass	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	91308b255783ad4029e5575028c18d7550832c51
ToppCell	Mild_COVID-19-Epithelial\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	DDR1 DNAH10 TACC2 PTPRF TMC5 MAP3K19	1.92e-05	199	123	6	72689bda7476930887ae007682fcab27f956f050
ToppCell	Control_saline-Mesenchymal_myocytic-Myofibroblastic-Myofibroblast\|Control_saline / Treatment groups by lineage, cell group, cell type	PPP1R12B WFDC1 TACC2 ZFPM2 FNDC1 VCL	1.97e-05	200	123	6	c5e051f1aac8dda376c342a9932785a23450e073
ToppCell	LPS_only-Epithelial_alveolar-AT_1-Differentiating_AT1\|LPS_only / Treatment groups by lineage, cell group, cell type	SFTPD MAGI3 CNTN6 WWC2 FOXP4 PTPRF	1.97e-05	200	123	6	2dadf317a42a7e27cc1fac74f91b806c93a57108
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 ZFPM2 FNDC1 VCL	1.97e-05	200	123	6	f599e4b051ac3dad11ad437e98dc8ea6754cca53
ToppCell	LPS_anti-TNF-Mesenchymal_myocytic-Pericyte\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B KCP WFDC1 ADAMTS8 VCL	1.97e-05	200	123	6	4e1e19214aeebbdca004de7faaf4cc9d18498591
ToppCell	LPS_IL1RA-Mesenchymal_myocytic-Pericyte\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B KCP WFDC1 ADAMTS8 VCL	1.97e-05	200	123	6	b22cae282591d8dead9869c2adbb9632615f50f7
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_alveolar-AT1\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	SFTPD MAGI3 TACC2 CNTN6 WWC2 PTPRF	1.97e-05	200	123	6	3d51aebf626dd4656ab4aac8a20d761b8062c42d
ToppCell	LPS_IL1RA_TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	TCAF1 ADAMTS1 PPP1R12B WFDC1 ADAMTS13 FNDC1	1.97e-05	200	123	6	09537dc25f8b8b4654a7c183827ee1522a41a4e0
ToppCell	LPS_only-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast\|LPS_only / Treatment groups by lineage, cell group, cell type	TCAF1 ADAMTS1 PPP1R12B WFDC1 ADAMTS13 FNDC1	1.97e-05	200	123	6	a9ff3210127000b3dd9e97136163c98c2b0817d7
ToppCell	LPS_only-Epithelial_alveolar-AT_1\|LPS_only / Treatment groups by lineage, cell group, cell type	SFTPD MAGI3 CNTN6 WWC2 FOXP4 PTPRF	1.97e-05	200	123	6	9a6ae40f3e17cd44ee5fd73260713b920aa2ea15
ToppCell	LPS_IL1RA-Mesenchymal_myocytic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	ADAMTS1 PPP1R12B WFDC1 ADAMTS8 FNDC1 VCL	1.97e-05	200	123	6	77631c471cc5d453a749784f838cfa6408caf09b
ToppCell	droplet-Liver-nan-3m-Myeloid-nan\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CTC1 KCP CD163 CABLES1 IQGAP1	2.74e-05	127	123	5	39fa20a55de3af1a62ab5dfa4877879db3935ac2
ToppCell	LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SFTPD MAGI3 TACC2 CNTN6 FOXP4	3.07e-05	130	123	5	6434d9106ccb38786dad36fab80163dfc07b6eb7
ToppCell	E18.5-samps-Mesenchymal-Matrix_fibroblast-matrix_-_mature_2\|E18.5-samps / Age Group, Lineage, Cell class and subclass	VWCE SYNE4 CD163 CNTN6 FOXP4	3.18e-05	131	123	5	f2eee150f5cff852e8f52f09b35e26f17d80833b
ToppCell	Int-URO-Lymphocyte-T_NK-CD8_Naive\|Int-URO / Disease, Lineage and Cell Type	LINC01547 TACC2 VWCE PASK TRIM47	6.46e-05	152	123	5	52d6f9cf1f4637c922f582705d625b4cbe3dc0c2
ToppCell	PBMC-Control-cDC_8\|Control / Compartment, Disease Groups and Clusters	RAB44 NRP2 ZSWIM9 MEGF8 LRRC74B	6.66e-05	153	123	5	db1a6914f2033fb0748e0523cffe5d6dc4e901be
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	CCDC88B WDFY4 ENAM CD80 CCSER1	7.09e-05	155	123	5	9f937ae48767fdcf1a944af4de0530d9c0ab441d
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Trm_Tgd\|lymph-node_spleen / Manually curated celltypes from each tissue	KCP VWCE DLL1 CABLES1 ZNF71	7.09e-05	155	123	5	b0e456c4915076e1d38282e116a6eb3230ae80dc
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma\|TCGA-Brain / Sample_Type by Project: Shred V9	NHLRC2 WDFY4 ZSWIM9 MEGF8 KIF1C	8.73e-05	162	123	5	810881210e015c788814e4fe8d7a24c929cf2621
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1-cDC1_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BICRA CCDC88B WDFY4 TIAM1 NINL	8.73e-05	162	123	5	388670cf3acef17df971c0d8ae3ce14398945192
ToppCell	E18.5-Immune-Immune_Myeloid-DC-cDC1\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	BICRA CCDC88B WDFY4 TIAM1 NINL	8.73e-05	162	123	5	9333d923225df7bfdf6b3a4c32816751315aec50
ToppCell	severe-unassigned\|World / disease stage, cell group and cell class	ZNF133 BICRA NUDT6 DNMBP ITPRIPL1	9.25e-05	164	123	5	b3a45c150df6594debeeca400cc58d30ef662756
ToppCell	3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory\|Lung / Manually curated celltypes from each tissue	DLL1 GLA CD80 CEP131 CCSER1	9.25e-05	164	123	5	7766900740f67dbbe3c4d90fbfdcc1665cee6515
ToppCell	368C-Myeloid-Macrophage-FABP4+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	MAGI3 WFDC1 ADAMTS8 CLIP3 ITPRIPL1	9.52e-05	165	123	5	3d2acdae0dd2b79a15f74158e8e566ce22b4218e
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GHRL CCDC88B RAB44 TMC5 SCIN	1.09e-04	170	123	5	a6fa0cab1fa829ec601fe48306b4c43c83425b04
ToppCell	390C-Endothelial_cells-Endothelial-C_(Capillary_Aerocyte_)-\|Endothelial_cells / Donor, Lineage, Cell class and subclass (all cells)	GHRL CCDC88B RAB44 TMC5 SCIN	1.09e-04	170	123	5	b40255eee45eb18b5a297336d7f3845fd8f8aa3b
ToppCell	343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_1\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	DDR1 BICRA DIDO1 WWC2 DNMBP	1.16e-04	172	123	5	d65ffff3e341af34a043a0d802d7ba4b69de36e9
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GHRL ADAM15 RAB44 NRP2 CEP131	1.16e-04	172	123	5	ac20766d1fd43eab8c3ff5e7418a6b38bebf0bd5
ToppCell	droplet-Liver-Npc-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	EMILIN1 NRP2 TIAM1 ARHGAP31 GIMAP6	1.16e-04	172	123	5	a6fb1bde8d942c7b5caaf7bd14de0b7ce32fda55
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Myeloid-Dendritic-conventional_dendritic_cell-DC_c2-CD1C\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	GHRL ADAM15 RAB44 NRP2 CEP131	1.16e-04	172	123	5	3fd1bc4a8ced0bf9e26ca4ce6d83b5b97bbc2556
ToppCell	367C-Lymphocytic-ILC-ILC-2\|367C / Donor, Lineage, Cell class and subclass (all cells)	HAUS5 DRAXIN AP5B1 SEC63 ITPRIPL1	1.19e-04	173	123	5	0451450605521fecb27a958628870d268adfb023
ToppCell	AT1_cells-Donor_03\|World / lung cells shred on cell class, cell subclass, sample id	TACC2 CNTN6 WWC2 PTPRF VCL	1.19e-04	173	123	5	3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e
ToppCell	droplet-Bladder-Unstain-18m-Hematologic-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DOK2 CCDC88B RAB44 CD163 GIMAP6	1.22e-04	174	123	5	773329bb91b97578df138446cf62101dd0dad758
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	DDR1 SFTPD MAGI3 PTPRF TMC5	1.22e-04	174	123	5	edf839d79ac58921f4e788f3b2cb2ae0d6af4b9e
ToppCell	367C-Epithelial_cells-Epithelial-I_(AT1)\|367C / Donor, Lineage, Cell class and subclass (all cells)	DDR1 SFTPD MAGI3 PTPRF TMC5	1.22e-04	174	123	5	65539f69100db0b7d90b1b39ee15ab8281f86461
Drug	N-vinylcaprolactam	AMY1A AMY1B AMY1C VCL	5.58e-08	8	123	4	CID000075227
Drug	AC1N3UXZ	AMY1A AMY1B AMY1C	1.54e-07	3	123	3	CID004118625
Drug	chloroisocyanuric acid	FOXM1 AMY1A AMY1B AMY1C	3.88e-07	12	123	4	CID000017921
Drug	II 13	AMY1A AMY1B AMY1C CNTN3	5.58e-07	13	123	4	CID003040488
Drug	N-PMT	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID000194224
Drug	AC1MQT4V	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID003482066
Drug	SAIB-SG	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID002735139
Drug	2-nitropropyl acetate	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID013573844
Drug	Dembrexine	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID000072009
Drug	g lw	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID000444139
Drug	beta-santalene	AMY1A AMY1B AMY1C	6.13e-07	4	123	3	CID000010534
Drug	2ai8	AMY1A AMY1B AMY1C CD80	1.06e-06	15	123	4	CID005289329
Drug	Deposiston	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID003080829
Drug	2-[[(2-amino-1,3-thiazol-4-yl)-(2-oxoethylcarbamoyl)methylidene]amino]oxy-2-methyl-propanoic Acid	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID010358258
Drug	lunularic acid	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID000161413
Drug	himachalene	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID000015095
Drug	actinidine	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID000068231
Drug	2TAA	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID000127374
Drug	cimicifugic acid A	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID006449879
Drug	silver perchlorate	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID000024562
Drug	AC1L4DZ4	AMY1A AMY1B AMY1C	1.53e-06	5	123	3	CID000155287
Drug	Tony Red	AMY1A AMY1B AMY1C ZFPM1	2.34e-06	18	123	4	CID005379348
Drug	2-amino-6-picoline	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000015765
Drug	phenol blue	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000075078
Drug	R 623	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID003027594
Drug	Gu-4	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000448679
Drug	Borane dimethylamine complex	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID009898794
Drug	AC1L3OV4	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000092801
Drug	tris(hydroxyethyl)aminomethane	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000448009
Drug	4,6-O-3-ketobutylidene maltopentaose	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID003083414
Drug	dimethylaminomethylferrocene	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000102082
Drug	mono-6-deoxy-6-fluorocyclomaltoheptaose	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000127364
Drug	(2S)-2-acetamido-3-[(3E)-3-[(4-arsonophenyl)hydrazono]-4-oxo-cyclohexa-1,5-dien-1-yl]propanoic acid	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID009577343
Drug	CNP-G3	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID003082910
Drug	AC1OAGH8	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID006857368
Drug	vermella	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000203726
Drug	hymenin	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000010499
Drug	mercuric thiocyanate	AMY1A AMY1B AMY1C	3.04e-06	6	123	3	CID000011615
Drug	AC1L5BOU	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID000174858
Drug	methyl blue	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID011969534
Drug	3KBG5CNP	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID003083250
Drug	AC1L9UU3	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID000071762
Drug	Paramax	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID000156411
Drug	BG5P	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID003082752
Drug	amino-methyl	AMY1A AMY1B AMY1C	5.30e-06	7	123	3	CID000142005
Drug	boric acid gel	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID003016474
Drug	AC1NSVJM	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID005317411
Drug	9-azidoacridine	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000146692
Drug	acrinor	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID005489637
Drug	Triap	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000013356
Drug	desethylaprophen	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000163919
Drug	NSC300622	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000028426
Drug	theodrenaline	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000071857
Drug	rhodanile blue	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000073372
Drug	azintamide	AMY1A AMY1B AMY1C	8.45e-06	8	123	3	CID000071105
Drug	fuchsin	AMY1A AMY1B AMY1C SPN	1.11e-05	26	123	4	CID000012447
Drug	Quipazine dimaleate salt [4774-24-7]; Up 200; 9uM; PC3; HT_HG-U133A	SPN SFTPD HAUS5 ZFPM2 ZNF358 RAB3GAP2 SCIN KIF1C	1.20e-05	197	123	8	5887_UP
Drug	GSAD	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID009909127
Drug	GU-3	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID000448687
Drug	alpha-maltosyl fluoride	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID000194237
Drug	trestatin A	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID003054994
Drug	zingiberene	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID000092776
Drug	Atonik	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID000069471
Drug	H 187	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID000001742
Drug	mercuric nitrate	AMY1A AMY1B AMY1C	1.26e-05	9	123	3	CID000024864
Drug	AC1L1SUV	AMY1A AMY1B AMY1C ETFDH	1.74e-05	29	123	4	CID000009347
Drug	AC1LAC07	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000485275
Drug	I ZE	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID009549200
Drug	trans-cinnamamide	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000012135
Drug	CG-120	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000171403
Drug	eicosa-11,14-dienoic acid	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000003208
Drug	UDP-pyridoxal	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000126789
Drug	Glc)4	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000189098
Drug	Ro 20-0083	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID003082332
Drug	naphthalene-1,3,6,8-tetrol	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000440202
Drug	AC1L3M0Q	AMY1A AMY1B AMY1C	1.80e-05	10	123	3	CID000118008
Drug	Tempamine	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000550942
Drug	L-tert-leucine	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000164608
Drug	validamycin D	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000166726
Drug	AMO-1618	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000017103
Drug	FG5P	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000127486
Drug	AC1L8PXO	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000430710
Drug	CNP-G5	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000127309
Drug	HgI2	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID000024485
Drug	2C KM	AMY1A AMY1B AMY1C	2.46e-05	11	123	3	CID009549196
Drug	N,N-dimethylproline	AMY1A AMY1B AMY1C ZFPM1 FUCA2	2.70e-05	65	123	5	CID000000554
Drug	glyciphosphoramide	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000197092
Drug	chitosan	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000071853
Drug	azaprophen	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000129486
Drug	Avenin	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000095924
Drug	AC1L4W0B	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000193311
Drug	3-hydr-oxy-2-naphthohydrazide	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000072699
Drug	H2folate	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID000168809
Drug	CTK2H7378	AMY1A AMY1B AMY1C	3.27e-05	12	123	3	CID005462310
Drug	PNPC	AMY1A AMY1B AMY1C SFTPD	3.73e-05	35	123	4	CID000165125
Drug	2-aminopyridine	AMY1A AMY1B AMY1C ENAM CHPF	3.88e-05	70	123	5	CID000010439
Drug	pie-like	AMY1A AMY1B AMY1C	4.23e-05	13	123	3	CID000017384
Drug	methyl 1'-epiacarviosin	AMY1A AMY1B AMY1C	4.23e-05	13	123	3	CID000197426
Drug	isoacarbose	AMY1A AMY1B AMY1C	4.23e-05	13	123	3	CID000449165
Drug	AC1NBNXD	AMY1A AMY1B AMY1C	4.23e-05	13	123	3	CID004470981
Disease	5-dodecenoylcarnitine (C12:1) measurement	ETFDH PKD2L1	1.56e-05	2	117	2	EFO_0800555
Disease	azoospermia (implicated_via_orthology)	PTPRD PTPRF PTPRS	1.66e-04	27	117	3	DOID:14227 (implicated_via_orthology)
Disease	alpha-amylase 1 measurement	AMY1A AMY1C	5.51e-04	9	117	2	EFO_0801371
Disease	synaptotagmin-11 measurement	RREB1 ZFPM2	5.51e-04	9	117	2	EFO_0802108
Disease	Alzheimer disease, fasting blood glucose measurement	ETFDH CRY2	5.51e-04	9	117	2	EFO_0004465, MONDO_0004975
Disease	C-X-C motif chemokine 5 measurement	ZFPM1 ZFPM2	6.87e-04	10	117	2	EFO_0008058
Disease	adseverin measurement	DNMBP SCIN	6.87e-04	10	117	2	EFO_0801358
Disease	glucagon-like peptide-1 measurement	BICRA ENAM	6.87e-04	10	117	2	EFO_0008465
Disease	systemic lupus erythematosus (is_marker_for)	SFTPD ADAMTS13 CD80	8.68e-04	47	117	3	DOID:9074 (is_marker_for)
Disease	disks large homolog 3 measurement	ZFPM1 ZFPM2	1.00e-03	12	117	2	EFO_0802472
Disease	tumor necrosis factor receptor superfamily member EDAR measurement	ZFPM1 ZFPM2	1.00e-03	12	117	2	EFO_0008310
Disease	dickkopf‐related protein 1 measurement	ZFPM1 ZFPM2	1.00e-03	12	117	2	EFO_0010620
Disease	body mass index, fasting blood glucose measurement	ETFDH RREB1 CRY2	1.10e-03	51	117	3	EFO_0004340, EFO_0004465
Disease	Erythrocyte Mean Corpuscular Hemoglobin Test	ETFDH GLA	1.18e-03	13	117	2	C0369183
Disease	Modic type vertebral endplate changes	PTPRD SCIN	1.18e-03	13	117	2	HP_0030775
Disease	Finding of Mean Corpuscular Hemoglobin	ETFDH GLA	1.18e-03	13	117	2	C1261502
Disease	Cocaine-Related Disorders	GHRL HDAC5 DNAH8 CCSER1	1.23e-03	117	117	4	C0236736
Disease	unipolar depression, anxiety	ZKSCAN2 PTPRD	1.38e-03	14	117	2	EFO_0003761, EFO_0005230
Disease	Cocaine Abuse	GHRL HDAC5 DNAH8 CCSER1	1.67e-03	127	117	4	C0009171
Disease	Cocaine Dependence	GHRL HDAC5 DNAH8 CCSER1	2.32e-03	139	117	4	C0600427
Disease	visceral:subcutaneous adipose tissue ratio	DNAH10 CNTN6 TBXT	2.74e-03	70	117	3	EFO_0004767
Disease	cytotoxicity measurement, response to metformin	AQP12A CCSER1	3.12e-03	21	117	2	EFO_0006952, GO_1901558
Disease	free androgen index	DDR1 ZFPM1 RREB1 ZFPM2 PTPRF DNMBP	3.83e-03	374	117	6	EFO_0007005
Disease	Autistic Disorder	DLL1 WDFY4 NRP2 PASK CNTN3	3.91e-03	261	117	5	C0004352

Protein segments in the cluster

Peptide	Gene	Start	Entry
TPQEDQWDGVGPIPG	PKP4	796	Q99569
NQEWPEGSSPGLTEG	LINC01547	21	P58512
VELGPWAGDFGPDLL	AQP12A	46	Q8IXF9
GREAPQGELVPEAWG	CCDC88B	626	A6NC98
KEGTGWGLPEPQGND	CTC1	776	Q2NKJ3
WPLPNIGGTEEQQAE	ADAM15	21	Q13444
LPRGPEWEVETGEGQ	ADAMTS8	161	Q9UP79
WGQEVISGNEDPEGV	DDR1	136	Q08345
GKDVNDWVGPPNDNG	AMY1B	366	P0DTE7
GKDVNDWVGPPNDNG	AMY1C	366	P0DTE8
ERIVDVAGPGGWNDP	GLA	251	P06280
KEEGPAAWEGPNQDL	CUEDC2	186	Q9H467
GVPEPGWFEGELEGR	DNMBP	176	Q6XZF7
GKDVNDWVGPPNDNG	AMY1A	366	P0DUB6
PSADWPLQGVEENGG	CCSER1	601	Q9C0I3
VELGPWAGDFGPDLL	AQP12B	46	A6NM10
GGFPEPHLSWLENGE	CD80	166	P33681
EGGEQSLPPEGNWTL	ARMCX5	236	Q6P1M9
GWSQTINPEDDTDPG	ADAMTS13	156	Q76LX8
ETQEGGWDEPPNFVQ	IQGAP1	701	P46940
PGLQDGEVEGHPVWA	NUP93	306	Q8N1F7
QEDEEPEWRGGAVQP	RALBP1	606	Q15311
GDEPGPQRSVEGWIL	RBM8A	61	Q9Y5S9
EGWLPLSGGQGQSED	RBSN	441	Q9H1K0
EEAPLPGLFGDNDDW	RAB44	356	Q7Z6P3
EGEDEGAQWSPQDPA	ADAMTS1	221	Q9UHI8
DDGWGAWEENEPQEP	RAB3GAP2	46	Q9H2M9
KVGDFGDAINWPTPG	LARP1	166	Q6PKG0
TLDPWQGQDPAEGGQ	PASK	421	Q96RG2
ESALELWGGPEPGTQ	DOK2	176	O60496
GQELPEFWEALGGEP	FLII	696	Q13045
PGTGLIPDHGDWDIN	MAGI3	1101	Q5TCQ9
DAWAGPAQVPEEGAV	SPN	301	P16150
LQDGEAWPPEGSVNI	NCR3LG1	331	Q68D85
KPGQPGVETDDWDGP	ZFPM2	86	Q8WW38
PEEWGGAGAQAEELA	JPH4	496	Q96JJ6
GAPAAGGEEEWGQQQ	HEXIM1	131	O94992
WKFPGGLSEPEEDIG	NUDT6	171	P53370
PTIGEWGLQGLPGDD	DNAH8	3436	Q96JB1
WSGPDELEPVVQDGQ	ZFPM1	86	Q8IX07
AQPGEEWLQVDLGTP	NRP2	481	O60462
QVPGEQPGSWGFREV	MEGF8	1741	Q7Z7M0
ESSPGGNLGWEPDIK	PI4KA	1981	P42356
ENEEGGEVPWAPPEG	KIF1C	881	O43896
WKGEGAPGQPAEDSV	FOXP4	231	Q8IVH2
QDTPEVDEGGGWLPQ	MRGPRX3	296	Q96LB0
QPQAPSWPAAEEGEG	AP5B1	236	Q2VPB7
PELQGIVGDWWEQPG	HAUS5	586	O94927
DGWEQDLSVPEFPEG	NHLRC2	46	Q8NBF2
FTDWPEQGVPKSGEG	PTPRS	1841	Q13332
DMGWPFQADGQEGPL	ITPRIPL1	91	Q6GPH6
AVQEQYGGGSIPWDP	PIKFYVE	901	Q9Y2I7
QPEVLWSDGDGGAPD	FUCA2	221	Q9BTY2
DPSQNINWVVPEGGG	ETFDH	596	Q16134
EWGPGLPSQAQDGAV	DRAXIN	66	Q8NBI3
GRLPPQDAEWGGGEE	CABLES1	76	Q8TDN4
ELGFPTEGLGPAVWQ	CRY2	216	Q49AN0
WLRPEDGGQAEGAED	GHRL	56	Q9UBU3
DLTEKLEGQGGPFPW	DLL1	531	O00548
EGGGWDVEEDLELPP	COPA	876	P53621
AESPPGGEWIEIDGF	FNDC1	126	Q4ZHG4
PAGSEQDGWKAEPGE	DIDO1	1626	Q9BTC0
WGVDFQLGSDVPDPG	ADAM9	601	Q13443
WESIPEELQNGEGFG	CNTN6	721	Q9UQ52
TREKEPPGWGQGQGE	BRF2	321	Q9HAW0
PGLDEDPLGPDNINW	FOXM1	741	Q08050
GDEVFPGQNRWGEEL	ENAM	661	Q9NRM1
SEEQEESWPGAPGGL	EMILIN1	421	Q9Y6C2
NVAWTGGVDPPIGDV	HDAC5	921	Q9UQL6
GQWVGVELDEPEGKN	CLIP3	321	Q96DZ5
AQGTGDPDWEAPGLP	BICRA	1456	Q9NZM4
EAEFGQGTGPIWLNE	CD163	981	Q86VB7
DTEGVWANPGELPGQ	DNAH10	2376	Q8IVF4
DDWGLQGNREGPGVL	SBK3	306	P0C264
QLDSQQEGWVPEAGP	CEP131	546	Q9UPN4
GQEGQWPPRDEGLKA	PRRT3	176	Q5FWE3
WDPVPEELQNGEGFG	CNTN3	721	Q9P232
NEEEDPSGGRQDWQP	MAP3K19	61	Q56UN5
SGVPEAEQGPEANWD	LRRC74B	26	Q6ZQY2
TDWPEQGVPKTGEGF	PTPRF	1801	P10586
TDWPEQGVPKSGEGF	PTPRD	1806	P23468
LHDPTQGTEPNGEGW	REG3A	106	Q06141
WEQLRGPGGNEDGPQ	TRIM47	381	Q96LD4
QDLEVEGDSDWPGPG	SYNE4	216	Q8N205
ENPGPWGELATDNII	TCAF1	656	Q9Y4C2
GQGSEDVPGEESWLE	GIMAP6	256	Q6P9H5
QEGEEPEEFWNSLGG	SCIN	581	Q9Y6U3
DGEEFAEGVQWEPDG	KCP	431	Q6ZWJ8
PQGSWQEQLAAPEEG	NINL	1031	Q9Y2I6
WVGGSVPNLGPAEQE	SLC39A5	21	Q6ZMH5
AGEGAGENWEPRVLP	CHPF	76	Q8IZ52
GGNGWLLDGPEEVLQ	WFDC1	126	Q9HC57
EEWLGPENQPSGEDG	ZBTB37	251	Q5TC79
GPWLEDEPGRGAQGE	ZSWIM9	451	Q86XI8
EESGQEEPRGPDGDW	WWC2	881	Q6AWC2
AAGEAGPDWFPEGQE	ZFHX2	366	Q9C0A1
GPDWFPEGQEEDGGL	ZFHX2	371	Q9C0A1
SQQPPGGGDTDRWVE	TIAM1	1471	Q13009
NWAPGEPNDDGGSED	SFTPD	336	P35247
VTAGWPSEPGQGDLN	RREB1	1636	Q92766
LLGWVGGDPNEDAAE	PFAS	1166	O15067
SARLDQEPWEPGGQE	SNX15	241	Q9NRS6
QEPWEPGGQEEEEDG	SNX15	246	Q9NRS6
AQNWLADPNGGPEGE	VCL	391	P18206
DDNGVEFPIGQIWSP	VWCE	571	Q96DN2
GTVLGDVQLPPWADG	WDFY4	2716	Q6ZS81
ESRKNWEEFGNPDGP	SEC63	156	Q9UGP8
TVPEGAIWEGSGLQP	TACC2	681	O95359
EEPGDSQQPGYSQWG	TBXT	231	O15178
ESGGWPEEEKPLGAE	ARHGAP31	531	Q2M1Z3
TPDPWGVQGGQESEV	PKD2L1	766	Q9P0L9
EQGEEPWVGDGEIPS	ZNF84	61	P51523
GRPWSDQAEGPEGEG	ZNF133	136	P52736
DLPIWGIVGEADENG	TM9SF3	136	Q9HD45
FLWGKQEEGEGFPPA	ZSWIM3	676	Q96MP5
EQGEGSEDEWEQVGP	USP10	571	Q14694
RGGIEVEPQEPTGWE	ZKSCAN2	606	Q63HK3
DPVGSLWGENDYPEG	TMC5	281	Q6UXY8
QPDIGEEPWGLSQLD	ZNF746	211	Q6NUN9
EFEGRGGPLPQEEKW	WDR33	1031	Q9C0J8
DAGAEWEPLGIPQGN	ZNF71	51	Q9NQZ8
PWGDGDLPLEEENPN	KIAA0586	1136	Q9BVV6
GESPEWVQEQGALLG	ZNF358	551	Q9NW07
QLEGGEEQWVPDPQD	ZNF641	161	Q96N77
VPATEAGEGQQPWGR	PPP1R12B	696	O60237